The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Colorectal and Other Cancer Risks for Carriers and Noncarriers From Families With a DNA Mismatch Repair Gene Mutation: A Prospective Cohort Study
Open accessAbstract
Purpose: To determine whether cancer risks for carriers and noncarriers from families with a mismatch repair (MMR) gene mutation are increased above the risks of the general population. Patients and Methods: We prospectively followed a cohort of 446 unaffected carriers of an MMR gene mutation (MLH1, n = 161; MSH2, n = 222; MSH6, n = 47; and PMS2, n = 16) and 1,029 their unaffected relatives who did not carry a mutation every 5 years at recruitment centers of the Colon Cancer Family Registry. For comparison of cancer risk with the general population, we estimated country-, age-, and sex-specific standardized incidence ratios (SIRs) of cancer for carriers and noncarriers. Results: Over a median follow-up of 5 years, mutation carriers had an increased risk of colorectal cancer (CRC; SIR, 20.48; 95% CI, 11.71 to 33.27; P < .001), endometrial cancer (SIR, 30.62; 95% CI, 11.24 to 66.64; P < .001), ovarian cancer (SIR, 18.81; 95% CI, 3.88 to 54.95; P < .001), renal cancer (SIR, 11.22; 95% CI, 2.31 to 32.79; P < .001), pancreatic cancer (SIR, 10.68; 95% CI, 2.68 to 47.70; P = .001), gastric cancer (SIR, 9.78; 95% CI, 1.18 to 35.30; P = .009), urinary bladder cancer (SIR, 9.51; 95% CI, 1.15 to 34.37; P = .009), and female breast cancer (SIR, 3.95; 95% CI, 1.59 to 8.13; P = .001). We found no evidence of their noncarrier relatives having an increased risk of any cancer, including CRC (SIR, 1.02; 95% CI, 0.33 to 2.39; P = .97). Conclusion: We confirmed that carriers of an MMR gene mutation were at increased risk of a wide variety of cancers, including some cancers not previously recognized as being a result of MMR mutations, and found no evidence of an increased risk of cancer for their noncarrier relatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Self-citationJärvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337
Cancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome
Schmeler, K. M., Lynch, H. T., Chen, L.-M., Munsell, M. F., Soliman, P. T., Clark, M. B., Daniels, M. S., White, K. G., Boyd-Rogers, S. G., Conrad, P. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052627 · Cited by 794
Extracolonic cancer in hereditary nonpolyposis colorectal cancer
Watson, P., & Lynch, H. T. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3<677::aid-cncr2820710305>3.0.co;2-# · Cited by 738
Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome
Aarnio, M., Mecklin, J., Aaltonen, L. A., Nyström‐Lahti, M., & Järvinen, H. J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640613 · Cited by 599
The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations
Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J. D., Lindblom, A., Lagerstedt, K., Thibodeau, S. N., Lindor, N. M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.026 · Cited by 550
Self-citationRisk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
Canto, M. I., Goggins, M., Yeo, C. J., Griffin, C., Axilbund, J. E., Brune, K., Ali, S. Z., Jagannath, S., Petersen, G. M., Fishman, E. K., et al. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00244-7 · Cited by 448
Vasen, H. F. A., Stormorken, A., Menko, F. H., Nagengast, F. M., Kleibeuker, J. H., Griffioen, G., Taal, B. G., Moller, P., & Wijnen, J. T. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4074 · Cited by 406
Newcomb, P. A., Baron, J., Cotterchio, M., Gallinger, S., Grove, J., Haile, R., Hall, D., Hopper, J. L., Jass, J., Le Marchand, L., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0648 · Cited by 389
Self-citationPrediction of Germline Mutations and Cancer Risk in the Lynch Syndrome
Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., Watson, P., Gruber, S. B., Euhus, D., Kinzler, K. W., et al. (2006) · JAMA · doi:10.1001/jama.296.12.1479 · Cited by 384
Self-citationRisks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Baglietto, L., Lindor, N. M., Dowty, J. G., White, D. M., Wagner, A., Gomez Garcia, E. B., Vriends, A. H. J. T., Dutch Lynch Syndrome Study Group, Cartwright, N. R., Barnetson, R. A., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp473 · Cited by 376
Self-citationDecrease in Mortality in Lynch Syndrome Families Because of Surveillance
de Jong, A. E., Hendriks, Y. M. C., Kleibeuker, J. H., de Boer, S. Y., Cats, A., Griffioen, G., Nagengast, F. M., Nelis, F. G., Rookus, M. A., & Vasen, H. F. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.032 · Cited by 302
Population-Based Family History–Specific Risks for Colorectal Cancer: A Constellation Approach
Taylor, D. P., Burt, R. W., Williams, M. S., Haug, P. J., & Cannon–Albright, L. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.044 · Cited by 235
Scott, R. J., McPhillips, M., Meldrum, C. J., Fitzgerald, P. E., Adams, K., Spigelman, A. D., du Sart, D., Tucker, K., & Kirk, J. (2001) · The American Journal of Human Genetics · doi:10.1086/316942 · Cited by 202
Self-citationThe Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means?
Hampel, H., & de la Chapelle, A. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0345 · Cited by 170
A new variant database for mismatch repair genes associated with Lynch syndrome
Woods, M. O., Williams, P., Careen, A., Edwards, L., Bartlett, S. E., McLaughlin, J. R., & Younghusband, H. B. (2007) · Human Mutation · doi:10.1002/humu.20502 · Cited by 125
Walsh, M. D., Buchanan, D. D., Cummings, M. C., Pearson, S., Arnold, S. T., Clendenning, M., Walters, R., McKeone, D., Spurdle, A. B., Hopper, J. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3058 · Cited by 114
Self-citationChromosome 8q23.3 and 11q23.1 Variants Modify Colorectal Cancer Risk in Lynch Syndrome
Wijnen, J., Brohet, R. M., van Eijk, R., Jagmohan–Changur, S., Middeldorp, A., Tops, C. M. J., van Puijenbroek, M., Ausems, M. G. E. M., Gómez-García, E. B., Hes, F. J., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.033 · Cited by 92
Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome
Boyd, J. A., Rhei, E., Federici, M. G., Borgen, P. I., Watson, P. A., Franklin, B., Karr, B., Lynch, J., Lemon, S. J., & Lynch, H. T. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006030116357 · Cited by 91
Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families
Kauff, N. D., Mitra, N., Robson, M. E., Hurley, K. E., Chuai, S., Goldfrank, D. J., Wadsworth, E., Lee, J., Cigler, T., Borgen, P. I., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji281 · Cited by 71
A database to support the interpretation of human mismatch repair gene variants
Ou, J., Niessen, R. C., Vonk, J. J., Westers, H., Hofstra, R. M. W., & Sijmons, R. H. (2008) · Human Mutation · doi:10.1002/humu.20907 · Cited by 59
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2
Domchek, S. M., Gaudet, M. M., Stopfer, J. E., Fleischaut, M. H., Powers, J. M., Kauff, N. D., Offit, K., Nathanson, K. L., & Robson, M. E. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0611-y · Cited by 51
Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome
Jensen, U. B., Sunde, L., Timshel, S., Halvarsson, B., Nissen, A., Bernstein, I., & Nilbert, M. C. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0449-3 · Cited by 46
Pande, M., Amos, C. I., Osterwisch, D. R., Chen, J., Lynch, P. M., Broaddus, R. R., & Frazier, M. L. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0326 · Cited by 45
Felix, R., Bodmer, W. F., Fearnhead, N. S., van der Merwe, L., Goldberg, P. A., & Ramesar, R. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.09.004 · Cited by 39
IGF1 is a modifier of disease risk in hereditary non‐polyposis colorectal cancer
Reeves, S. G., Rich, D., Meldrum, C. J., Colyvas, K., Kurzawski, G., Suchy, J., Lubiński, J., & Scott, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23668 · Cited by 28
Cited by
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Tempero, M. A., Malafa, M. P., Al-Hawary, M., Behrman, S. W., Benson, A. B., Cardin, D. B., Chiorean, E. G., Chung, V., Czito, B., Del Chiaro, M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0017 · Cited by 1,304
Milestones of Lynch syndrome: 1895–2015
Lynch, H. T., Snyder, C. L., Shaw, T. G., Heinen, C. D., & Hitchins, M. P. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3878 · Cited by 810
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784
“6-fold higher risk).(39) 40 Patients with PC having histology characteristic of mismatch repair-deficient cancers (‘medullary ’ histology)(41) should have their pedigree evaluated for possible hereditary non-polyposis colorectal cancer.”
BackgroundVasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304356 · Cited by 746
Metadata
- Authors
- Win, A. K., Young, J. P., Lindor, N. M., Tucker, K. M., Ahnen, D. J., Young, G. P., Buchanan, D. D., Clendenning, M., Giles, G. G., Winship, I., Macrae, F. A., Goldblatt, J., Southey, M. C., Arnold, J., Thibodeau, S. N., Gunawardena, S. R., Bapat, B., Baron, J. A., Casey, G., Gallinger, S., Le Marchand, L., Newcomb, P. A., Haile, R. W., Hopper, J. L., & Jenkins, M. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-03-20
- Volume
- 30
- Issue
- 9
- Pages
- 958-964
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2156115771
- Cited by
- 333
- References
- 31
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.